A Randomized Controlled Trial of the Sagittal Alignment Difference Between Mako Robotic TKA and Manual TKA
Launched by CHINESE PLA GENERAL HOSPITAL · Jul 25, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the differences in knee alignment between two surgical methods for total knee replacement: one using the Mako robotic system and the other using traditional manual techniques. As more elderly people face knee problems, this research aims to understand which method provides better alignment and outcomes after surgery. The trial will take place at the People's Liberation Army General Hospital and plans to enroll about 100 participants who are between 18 to 80 years old and have osteoarthritis.
To be part of this study, participants should have knee osteoarthritis and be undergoing either the Mako robot-assisted or manual total knee replacement surgery. They will need to agree to take specific X-rays before and after their surgery and be in good physical and mental health to cooperate with the study. Throughout the trial, participants can expect close monitoring and follow-up to assess their recovery and the effectiveness of the surgery. This research is important because it will help improve surgical techniques and patient outcomes in knee replacements.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The age ranged from 18 to 80 years old;
- • 2. OA patients who underwent Mako robot assisted TKA and manual TKA (Stryker Triathlon prosthesis) in the Department of joint surgery of the PLA General Hospital from September 2024 to September 2026;
- • 3. All patients were required to take full-length anteroposterior and lateral radiographs of lower limbs, anteroposterior and lateral radiographs of both knees, and lower limb sagittal EOS before and after surgery;
- • 4. Physical and mental health, able to participate in and cooperate with the test;
- • 5. Patients are willing to participate in the study and sign written informed consent.
- Exclusion Criteria:
- • 1. People unable to conduct EOS inspection;
- • 2. Combined with knee meniscus injury, anterior cruciate ligament injury and other diseases that may affect the sagittal force line of the knee joint
- • 3. Combined with other diseases that may affect the study
- • 4. Patients refused to use their imaging data and knee score for this study.
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Wei Chai, doctorate
Study Director
Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported